Status:
ACTIVE_NOT_RECRUITING
Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
Tuberculosis, Pulmonary
Physical Disability
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This work aims to assess cardiopulmonary function and quality of life in people with sequelae of pulmonary tuberculosis undergoing rehabilitation. It is an experimental clinical study, with evaluation...
Detailed Description
Experimental clinical study, with evaluation before and after intervention, for a determined period of two years for data collection and one year for analysis and publication of results. Included part...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Pulmonary Tuberculosis,
- negative culture in induced sputum;
- pulmonary function report (spirometry), chest X-ray and complete blood count with biochemistry updated in the last month,
- in accordance with the Informed Consent Form.
Exclusion
- Non-cooperative patients,
- clinical instability and / or musculoskeletal injury that compromises Pulmonary Rehabilitation and limits the perception of physical capacity;
- comorbidities that may cause or accentuate dyspnea (Asthma, COPD, Pulmonary Fibrosis, Obesity);
- stable angina, severe arrhythmias and / or heart failure.
Key Trial Info
Start Date :
April 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04844502
Start Date
April 7 2021
End Date
August 1 2025
Last Update
December 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Rio de Janeiro, Rio de Janeiro, Brazil, 21941-617